Vivek Goyal

We feel there is still scope for margin improvement, especially with the brownfield expansion.

Fortis is their growth engine for India, and I think they will like to infuse fresh equity.

We are sticking to our guidance which we have provided in the beginning of the year 2% margin improvement.

We expect the margin to grow from the current level. Similar growth you can expect in the forthcoming years also, like 2% growth we have seen in the current financial year. Similar margin expansion growth we are expecting next financial year.

We are aiming around 70-71% occupancy level at the overall level. Because this brownfield expansion is on the existing facility, and these hospitals anyway are operating at 80% type of occupancy level. I think we will not be facing any challenge in occupancy side.

We are targeting margin expansion, and hopefully, we'll be seeing margin improvement year on year. Our ultimate target is to reach 25% sooner than later.

We have started the process of going right as per agreement, because IPO process not looking like we will be able to start immediately.

We are maintaining our margin guidance, that slowly, as we know, this ramp up will happen with the bed expansion. By next three to four years, we should be aiming towards 25%.

The price increase is mainly attributable toward the specialty mix change and the type of procedures we are doing, which is the high-end procedures.

I am expecting EBITDA margin of at least 30%-35% on this revenue brownfield expansion.